Pre-Conference Workshops (Thursday, 24 July 2025)

08.00 – 17.00

Registration

ROOM

Meeting Room 1

Junior Ballroom 1

Meeting Room 2

Chairpersons

Dr. Dewi Susanti Atmaja (Universitas Sari Mulia, INDONESIA)

Dr. Desak Ketut Ernawati (Universitas Udayana, INDONESIA)

Dr. Andi Hermansyah (Universitas Airlangga, INDONESIA)

08.00 – 12.00

Workshop 1: Evidence at Scale: Crafting Systematic Reviews & Meta-Analyses for Robust Research

Overview:

This 4-hour interactive workshop is designed to equip researchers with the practical tools and skills necessary to conduct systematic reviews and meta-analyses, thereby ensuring the synthesis of high-quality evidence for impactful research. The workshop is structured into four engaging 45-minute sessions, each including a dedicated Q&A segment. Participants will begin by learning the fundamentals of systematic reviews, including how to craft a structured research question and navigate PRISMA guidelines. The second session delves into the details of literature searches, study selection, and bias assessment, equipping attendees with essential techniques for rigorous methodology. The third session focuses on statistical methods for meta-analyses, covering fixed and random effects models, heterogeneity, and visualization tools like forest and funnel plots. The final session brings it all together with hands-on demonstrations of software, reporting best practices, and insights into future trends, such as AI-driven reviews. The workshop concludes with a wrap-up and networking session, offering opportunities to discuss key takeaways, explore potential collaborations, and identify future research directions. Whether you are a beginner or looking to refine your skills, this workshop provides a comprehensive approach to systematic reviews and meta-analyses, bridging theory with practical application.

Speakers:

1)      Elida Zairina, B.Pharm, MPH., PhD; Assoc. Professor, Department of Pharmacy Practice, Faculty of Pharmacy, Universitas Airlangga, INDONESIA: Building a Strong Foundation for Systematic Reviews.

2)      Dr Shamin bin Mohd Saffian, Assoc.Professor, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, MALAYSIA: Literature Search, Study Selection and Bias Assessment

3)      Dr Yola Moride, PhD FISPE, Senior Academic and Consultant in Pharmacoepidemiology and Therapeutic Risk Management, Institute for Health Care Policy and Aging Research, Rutgers University, USA: Meta-Analysis Methods – From Data to Interpretation and Hands-On Application

Workshop 2: Moving the Profession Forward with Board Certification in Pharmacy  - (supported by the Board of Pharmacy Specialties)

Overview:

The world is changing; innovative technologies and therapies are evolving, and the delivery of healthcare is becoming more complex. Practitioners, educators, and learners are expected to master an ever-broadening scope of knowledge. The Pharmacy Professional's approach has traditionally been to prepare “generalist” practitioners and most pharmacists practice as generalists today. In some countries, however, more specialized or “focused” areas of practice have emerged to meet the needs of patients and society. Certifications are being pursued to provide validated evidence of knowledge and competence in specialty areas of practice.

The session will comprise three presentations, followed by a question-and-answer session and discussion. The first presentation will discuss global trends in pharmacy practice, education, and regulation, as well as how practice and competence can evolve and advance throughout a pharmacist’s career. It will also explore the purpose and benefits of specialty certification, the process of establishing a new specialty certification, and potential changes in pharmacy education for the future. The final two presentations will focus on the benefits of board certification in clinical pharmacy practice. The discussion will focus on various examples of traditional and non-traditional pharmacy practice in the field of oncology and infectious diseases. The goal of the presentations is to highlight expanded roles and responsibilities for pharmacists.

Speakers:

1)      Michael Rouse BPharm (Hons), MPS, FFIP; Consultant for International Initiatives, Board of Pharmacy Specialties, and Senior Director, Global Initiatives, American Pharmacists Association, Washington, DC, USA: Specialty Education and Practice for Pharmacists for Improved Patient Care

2)      Alexandre (“Alex”) Chan, PharmD, MPH, FCCP, FISOPP, BCPS, BCOP, APh; Founding Chair, Department of Clinical Pharmacy Practice, Professor of Clinical Pharmacy, University of California Irvine, Irvine, California, USA; Member, Oncology Pharmacy Specialty Council, Board of Pharmacy Specialties: Oncology Pharmacy Certification: A Global Passport in my Professional Journey

3)      Lee Nguyen, PharmD, APh, BCPS, BCIDP; Health Sciences Associate Clinical Professor, Department of Clinical Pharmacy Practice, Susan & Henry Samueli College of Health Sciences, University of California Irvine, Irvine, California, USA; Vice Chair, Infectious Diseases Pharmacy Specialty Council, Board of Pharmacy Specialties. Infectious Diseases Pharmacy Board Certification: Moving the Profession Forward with Board Certification in Pharmacy: Perspective from an Infectious Disease Pharmacist

Workshop 3: Development and Validation of Patient-Reported Outcome Measures (PROMs)

Overview:

Patient-Reported Outcome Measures (PROMs) are questionnaires that enable patients to report on health outcomes and experiences from their perspective. Developing valid and reliable patient-reported outcomes measures (PROMs) requires careful planning and a rigorous methodological approach. This process is crucial for conceptualizing and operationalizing several key research questions in clinical research and practice.

In this workshop, participants will learn how to develop and validate PROMs through interactive discussions and case studies. This workshop will cover the following topics:

·        Conceptualization of PROMs and types of measurements

·        Delphi study for design and validation of PROMs

·        Field-testing: item reduction and data structure

·        Assessment of measurement properties, including content validity, internal consistency, criterion validity, construct validity, reproducibility, longitudinal validity, responsiveness, floor and ceiling effects, and interpretability

·        Essentials of Classical Test Theory and Item Response Theory (Rasch Analysis)

·        Cross-cultural adaptation of PROMs

·        Systematic reviews of measurement properties

·        Hands-on exercise in evaluating measurement properties

By the end of this workshop, the participants will have a comprehensive understanding of how to develop, test, and validate PROMs, ensuring they generate meaningful and actionable data for clinical practice and research.

Speakers:

1)      Sohail Ahmad, Pharm D, MSc (Clinical Pharmacy), CGCP, NHMRC Centre of Research Excellence on Achieving the Tobacco Endgame, School of Public Health, The University of Queensland, AUSTRALIA

2)      Yunita Nita, B.Pharm, MClinPharm, Dr. Assoc. Professor, Department of Pharmacy Practice, Faculty of Pharmacy, Universitas Airlangga, Surabaya, INDONESIA

12.00 – 13.00

Lunch Break

Junior Ballroom 1

Meeting Room 1

Meeting Room 2

Chairpersons

Dr. Febri Annuryanti (Universitas Airlangga, INDONESIA)

Dr. Eko Setiawan (Universitas Surabaya, INDONESIA)

Dr. Mahardian Rahmadi (Universitas Airlangga, INDONESIA)

13.00 – 17.00

Workshop 4: Innovations in Generic and Value-Added Medicines: Regulatory Pathways and Clinical Strategies (supported by Daewoong Pharmaceutical Co.Ltd)

Overview:

The aim of this workshop is not only to share knowledge on the development and approval of generic drugs from formulation, statistical, and clinical perspectives but also to highlight key considerations for the successful approval of generics using real case studies from the Indonesian market.

Speakers:

1)    Soyoung Lee, Professor, College of Pharmacy, Chungnam National University, SOUTH KOREA; Clinical Trial Design Consideration for Developing Generic and Incrementally Modified Drugs

2)      Jung-woo Chae, Professor, College of Pharmacy, Chungnam National University, SOUTH KOREA: Approved Strategies for Modified Drugs Based on IVIVC Modeling

3)      Hwi-yeol Yun, Professor, College of Pharmacy/Bio-AI Convergence research center, Chungnam National University, SOUTH KOREA: Statistical Consideration of Generic Approval

4)      Sangeun Cho, PhD. Head, Drug Discovery Team, Daewoong Pharmaceutical Co.Ltd, SOUTH KOREA: CMC Regulatory considerations for Application: IMD 505(b)(2), NDA 

5)      Taeheon Kim,PhD. Senior Research Scientist, Daewoong Pharmaceutical Co. Ltd, SOUTH KOREA: Application of PK/PD Modeling and Simulation to Overcome Bioequivalence Challenges in Sustained-Release Depot Formulations

Workshop 5: Case-based learning in Anticoagulation Management

Overview:

The workshop will provide essential foundation knowledge regarding anticoagulation therapy management. A focused overview of basic knowledge will be provided. This will be followed by case-based learning on how to manage real-life patients. In addition, quality improvement strategies at both institutional and national levels will be discussed and shared, drawing on best practices from the region.

Speakers:

1)      Surakit Nathisuwan, Professor, PharmD, BCPS, Faculty of Pharmacy, Mahidol University, THAILAND

2)      Dr.  Wenny Putri Nilamsari, S.Farm.,Sp.FRS, Faculty of Pharmacy, Universitas Airlangga, INDONESIA

Workshop 6: Stewardship in Practice: Navigating Antibiotic Management and Regulatory Guidelines

Overview:

Stewardship in Practice: Navigating Antibiotic Management and Regulatory Guidelines is a focused session designed for pharmacists who play a pivotal role in antimicrobial stewardship. This workshop will explore pharmacists’ expanding responsibilities in optimizing antibiotic use across diverse healthcare settings. Emphasizing evidence-based interventions, we will cover core principles, including formulary management, therapeutic drug monitoring, de-escalation strategies, and interprofessional collaboration. Special attention will be given to navigating current regulatory guidelines ensuring compliance while supporting effective clinical decision-making. Through practical case studies and real-world scenarios, participants will gain actionable tools to lead stewardship efforts, minimize resistance, and enhance patient safety. Whether you're working in a hospital, community, or long-term care setting, this session will empower you to translate regulatory expectations and stewardship goals into measurable impact.

Speakers:

1)      Franco WT CHENG, Lecturer, Department of Pharmacology and Pharmacy, HKUMed, The University of HONG KONG; Clinical Pharmacist Practitioner, Gleneagles Hong Kong, HONG KONG: Strategic Leadership in Antimicrobial Stewardship: Pharmacists at the Forefront of Rational Antibiotic Use

2)      Vivian Lee, Professor of the Centre for Learning Enhancement and Research at the Chinese University of Hong Kong, HONG KONG: Therapeutic Drug Monitoring and Formulary Optimization: Core Components of Stewardship Excellence

3)      Mariyatul Qibtiyah, Apt, SpFRS, Clinical Pharmacist, Dr Soetomo Hospital, Surabaya, INDONESIA: From Policy to Practice: Operationalizing Antimicrobial Stewardship in Accordance with National and Global Guidelines